Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07528196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Mar 20, 2026 to Aug 20, 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Acute respiratory distress syndrome (ARDS) is a common clinical syndrome in the ICU characterized by extremely high mortality and complex pathogenesis.At present, research on individualized treatment, phenotypic differences, and therapeutic efficacy in ARDS has become a hotspot.As characterized by syndrome differentiation, traditional Chinese medicine (TCM) treatment emphasizes interindividual heterogeneity and personalized management, which is expected to serve as a breakthrough in multi-target immune regulation for ARDS. The primary objective of the study is to investigate the effect of Xuanbai Shengmai Decoction on the prognosis of patients with ARDS in a prospective randomized controlled trial. The secondary objective is to evaluate the safety of Xuanbai Shengmai Decoction in the treatment of patients with ARDS.
Trial Details
NCT Number NCT07528196
Lead Sponsor Southeast University, China
Collaborators: Beijing Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Guangzhou Medical University, Jiangsu Province Hospital of Traditional Chinese Medicine, Subei People's Hospital of Jiangsu Province, Wuhan Hospital of Traditional Chinese Medicine, Shenzhen Hospital of Traditional Chinese Medicine
Conditions
(from sponsor)		 Acute Respiratory Distress Syndrome (ARDS)
Related terms Respiratory Distress Syndrome
Enrollment 308 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov